ALEXANDREA WARREN: Open Payments
NPI 1619300753 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 36 payments from 15 companies in 2025. Trend: 2023 $527 · 2024 $486 · 2025 $2,238
Travel & lodging: $1,489Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 12 | $1,731 |
| Corcept Therapeutics | 2 | $62 |
| Amneal Pharmaceuticals LLC | 4 | $62 |
| Ascendis Pharma Endocrinology Inc | 3 | $55 |
| Lilly USA, LLC | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Tandem Diabetes Care, Inc. | 1 | $42 |
| Sequel Med Tech, LLC | 2 | $36 |
| ABBVIE INC. | 2 | $32 |
| Dexcom, Inc. | 1 | $31 |
Products named: OMNIPOD, JARDIANCE, Korlym, UNITHROID, Yorvipath, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, TWIIST.
Industry payments across FL — which companies pay providers there.
